Results 101 to 110 of about 827 (180)
Carbapenem Resistance in Acinetobacter baumannii: Mechanisms, Therapeutics, and Innovations
The global rise of carbapenem-resistant Acinetobacter baumannii (CRAB) strains poses a critical challenge to healthcare systems due to limited therapeutic options and high mortality rates, especially in intensive care settings.
Joyce de Souza +5 more
doaj +1 more source
Sepsis-associated acute kidney injury (SA-AKI) often requires renal replacement therapy (RRT), which markedly alters antimicrobial pharmacokinetics (PK) and pharmacodynamics (PD). Novel β-lactam/β-lactamase inhibitor (BL/BLI) combinations broaden options
Antonio Lacquaniti +10 more
doaj +1 more source
It is estimated that antimicrobial resistance (AMR) is responsible for nearly 5 million human deaths worldwide each year and will reach 10 million by 2050.
Francesca Serapide +8 more
doaj +1 more source
Friends or foes? Novel antimicrobials tackling MDR/XDR Gram-negative bacteria: a systematic review
Gram-negative bacteria have been one of the most studied classes in the field of microbiology, especially in the context of globally alarming antimicrobial resistance levels to these pathogens over the course of the past decades.
Mihai Octavian Dan +2 more
doaj +1 more source
Nephrotoxicity of New Antibiotics: A Systematic Review
Drug-induced nephrotoxicity is a common and serious problem in clinical practice. We conducted a systematic review of studies reporting nephrotoxicity events associated with antibiotics approved since 2018.
Panagiotis Stathopoulos +3 more
doaj +1 more source
Opciones terapéuticas para infecciones por gérmenes ESKAPE en países de bajos recursos. Revisión sistemática [PDF]
Introducción: El término ESKAPE, acuñado hace más de una década, designa a un grupo de bacterias que tienen la habilidad de “escapar” a la acción de los antibióticos.
Castro Reyes, Evelyn Elizabeth +1 more
core +1 more source
Current Advances in Developing New Antimicrobial Agents Against Non-Tuberculous Mycobacterium
Non-tuberculous mycobacteria (NTM) comprise more than 190 species capable of causing severe pulmonary, lymphatic, cutaneous, and disseminated infections, particularly in immunocompromised populations.
Jane Cross +2 more
doaj +1 more source
Novel Insights into Carbapenem Resistance: Mechanisms, Diagnostics, and Future Directions
Carbapenems are essential for the treatment of severe infections caused by Gram-negative bacteria, particularly in critically ill and immunocompromised patients.
Ionela-Larisa Miftode +9 more
doaj +1 more source
Epidemiology, resistance genomics and susceptibility of Acinetobacter species: results from the 2020 Spanish nationwide surveillance study [PDF]
[Abstract]: Background: As increasing antibiotic resistance in Acinetobacter baumannii poses a global healthcare challenge, understanding its evolution is crucial for effective control strategies.
Alonso-Garcia, Isaac +11 more
core +2 more sources
BackgroundCarbapenem-resistant Gram-negative bacteria (CRGNB) pose a severe global health threat, yet comprehensive bibliometric analyses in this field remain limited.
Xiaotong Zhang +29 more
doaj +1 more source

